Related Experiment Video
Updated: Jun 11, 2026
07:52
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
The effects of heart failure on renal function
1Department of Medicine, University of Chicago, IL 60637, USA.
Cardiology Clinics
|July 13, 2010
Summary
This study explores heart-kidney interactions in heart failure and kidney disease, noting worsening kidney function negatively impacts heart failure outcomes. Novel therapies beyond traditional renin-angiotensin-aldosterone system blockade show promise.
Area of Science:
- Cardiology
- Nephrology
- Cardiorenal Medicine
Background:
- Growing recognition of complex heart-kidney interactions in clinical practice and research.
- Established classification system for cardiac and renal dysfunction.
- Worsening renal function significantly predicts poor outcomes in heart failure patients.
Purpose of the Study:
- To investigate the unclear etiology of concurrent cardiac and renal dysfunction.
- To explore alternative theories beyond the traditional underfilling hypothesis.
- To review current and novel therapeutic strategies for cardiorenal syndrome.
Main Methods:
- Literature review and synthesis of existing research on heart-kidney interactions.
- Analysis of evidence supporting venous congestion and intra-abdominal pressure in cardiorenal dysfunction.
- Evaluation of conventional and emerging therapeutic interventions.
Main Results:
- The etiology of cardiorenal dysfunction is multifactorial, with evidence supporting venous congestion and increased intra-abdominal pressure.
- Conventional therapies target the renin-angiotensin-aldosterone system.
- Novel approaches including extracorporeal therapy and adenosine pathway antagonists are under investigation.
Conclusions:
- Understanding heart-kidney interactions is crucial for managing patients with heart failure and kidney disease.
- Current therapeutic strategies are evolving, with promising novel interventions requiring further research.
- The complex interplay between cardiac and renal systems necessitates a comprehensive approach to treatment.
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...